Systematic review protocol: an assessment of the post-approval challenges of autologous CAR-T therapy delivery
Following recent regulatory approvals of two chimeric antigen receptor T-cell (CAR-T) therapies, the field now faces a number of post-approval challenges. These challenges are in some respects defined and, in others, uncertain due to the nascence of the field. At present, information pertaining to s...
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Journal article |
| Argitaratua: |
BMJ Journals
2019
|